Advances towards potential cancer therapeutics targeting Hippo signaling
Biochemical Society Transactions · 2024
DOI: 10.1042/bst20240244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von Rui Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of …. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction, Protein Serine-Threonine Kinases, Hippo Signaling Pathway. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 207 Literaturangaben.
Abstract (Originalsprache)
Decades of research into the Hippo signaling pathway have greatly advanced our understanding of its roles in organ growth, tissue regeneration, and tumorigenesis. The Hippo pathway is frequently dysregulated in human cancers and is recognized as a prominent cancer signaling pathway. Hence, the Hippo pathway represents an ideal molecular target for cancer therapies. This review will highlight recent advancements in targeting the Hippo pathway for cancer treatment and discuss the potential opportunities for developing new therapeutic modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, State Key Laboratory of Genetic En…
ORCID-Profile: Fa-Xing Yu
Zitieren
APA
Zhu, R., Jiao, Z., & Yu, F. X. (2024). Advances towards potential cancer therapeutics targeting Hippo signaling. Biochemical Society Transactions. https://doi.org/10.1042/bst20240244
Vancouver
Zhu R, Jiao Z, Yu FX. Advances towards potential cancer therapeutics targeting Hippo signaling. Biochemical Society Transactions. 2024. doi:10.1042/bst20240244
BibTeX
@article{Zhu2024,
author = {Zhu, Rui and Jiao, Zhihan and Yu, Fa-Xing},
title = {Advances towards potential cancer therapeutics targeting Hippo signaling},
journal = {Biochemical Society Transactions},
year = {2024},
doi = {10.1042/bst20240244}
}
EUVIMED